HCW Biologics Inc. (HCWB) Insider Trading -- Recent Executive & Director Transactions

6 insiders reported 15 Form 4 transactions for HCW Biologics Inc. (HCWB) over the past 18 months (most recent 2026-07-31). Recent activity: GARRETT SCOTT T (Director) Buy 7,736 shares, Flowers Lee (SVP of Business Development) Buy 7,736 shares, Wong Hing C (Chief Executive Officer) Buy 23,210 shares, GARRETT SCOTT T (Director) Buy 177,936 shares, Byam Rebecca (Chief Financial Officer) Buy 14,235 shares. Source: SEC Form 4.

DateInsiderTitleTypeSharesValue
2026-07-31GARRETT SCOTT TDirectorBuy7,736$19,998
2026-07-31Flowers LeeSVP of Business DevelopmentBuy7,736$19,998
2026-07-31Wong Hing CChief Executive OfficerBuy23,210$59,998
2026-05-27GARRETT SCOTT TDirectorBuy177,936$250,000
2026-05-27Byam RebeccaChief Financial OfficerBuy14,235$20,000
2026-05-27Wong Hing CChief Executive OfficerBuy113,879$160,000
2025-05-20GARRETT SCOTT TDirectorBuy13,423$100,001
2025-05-20Wong Hing CChief Executive OfficerBuy8,054$60,002
2025-05-20Winer Gary MDirectorBuy1,342$9,998
2025-05-09Greene Rick S.DirectorBuy962$25,012
2025-05-09Flowers LeeSVP of Business DevelopmentBuy962$25,012
2025-05-09Winer Gary MDirectorBuy2,308$60,008
2025-05-09Wong Hing CChief Executive OfficerBuy92,500$2.4M
2025-05-09GARRETT SCOTT TDirectorBuy5,385$140,010
2025-05-09Byam RebeccaChief Financial OfficerBuy8,462$220,012

Source: SEC Form 4 filings · as of 2026-07-31